| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.2 | 5e-10 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.2 | 8e-10 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.18 | 7e-07 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.38 | 2e-06 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-06 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.16 | 6e-06 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |